Investment analysts at StockNews.com assumed coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Get Free Report) in a report issued on Wednesday. The firm set a “sell” rating on the biopharmaceutical company’s stock.
Onconova Therapeutics Price Performance
Shares of Onconova Therapeutics stock opened at $1.00 on Wednesday. The business has a 50-day moving average of $0.82 and a 200 day moving average of $0.74. Onconova Therapeutics has a 12 month low of $0.55 and a 12 month high of $1.45. The stock has a market capitalization of $20.90 million, a price-to-earnings ratio of -1.09 and a beta of 1.38.
About Onconova Therapeutics
See Also
- Five stocks we like better than Onconova Therapeutics
- What Are Trending Stocks? Trending Stocks Explained
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Insider Trading – What You Need to Know
- Lockheed Martin Stock Aims for a Fresh All-Time High
- When to Sell a Stock for Profit or Loss
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Onconova Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconova Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.